121 related articles for article (PubMed ID: 11104898)
1. Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin.
Fukushima S; Kishimoto S; Takeuchi Y; Fukushima M
Adv Drug Deliv Rev; 2000 Dec; 45(1):65-75. PubMed ID: 11104898
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-deoxy-Delta7 -prostaglandin A1 methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826).
Fukushima S; Takeuchi Y; Kishimoto S; Yamashita S; Uetsuki K; Shirakawa S; Suzuki M; Furuta K; Noyori R; Sasaki H; Kikuchi Y; Kita T; Yamori T; Sawada J; Kojima M; Hazato A; Kurozumi S; Fukushima M
Anticancer Drugs; 2001 Mar; 12(3):221-34. PubMed ID: 11290870
[TBL] [Abstract][Full Text] [Related]
3. [Pharmaceutical and pharmacological development of antitumor prostaglandins].
Fukushima S; Kishimoto S; Takeuchi Y; Fukushima M; Suzuki M; Furuta K; Noyori R; Sasaki H; Kikuchi Y; Nakano M; Kurozumi S
Nihon Rinsho; 1998 Mar; 56(3):663-9. PubMed ID: 9549353
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo.
Sasaki H; Niimi S; Akiyama M; Tanaka T; Hazato A; Kurozumi S; Fukushima S; Fukushima M
Cancer Res; 1999 Aug; 59(16):3919-22. PubMed ID: 10463583
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins in the treatment of cancer.
Sasaki H; Fukushima M
Anticancer Drugs; 1994 Apr; 5(2):131-8. PubMed ID: 8049495
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
Kato T; Fukushima M; Kurozumi S; Noyori R
Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory properties of antitumor prostaglandins against topoisomerases.
Suzuki K; Uyeda M
Biosci Biotechnol Biochem; 2002 Aug; 66(8):1706-12. PubMed ID: 12353631
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats.
Goto J; Araki H; Otomo S; Aihara H
Drugs Exp Clin Res; 1986; 12(11):917-21. PubMed ID: 3816509
[TBL] [Abstract][Full Text] [Related]
9. Use of lipid microspheres as a drug carrier for antitumour drugs.
Mizushima Y; Shoji Y; Kato T; Fukushima M; Kurozumi S
J Pharm Pharmacol; 1986 Feb; 38(2):132-4. PubMed ID: 2870158
[TBL] [Abstract][Full Text] [Related]
10. Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to delta 7-prostaglandin A1 and delta 12-prostaglandin J2.
Sasaki H; Takada K; Terashima Y; Ekimoto H; Takahashi K; Tsuruo T; Fukushima M
Gynecol Oncol; 1991 Apr; 41(1):36-40. PubMed ID: 2026357
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin A and J: antitumor and antiviral prostaglandins.
Fukushima M; Kato T; Narumiya S; Mizushima Y; Sasaki H; Terashima Y; Nishiyama Y; Santoro MG
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():415-8. PubMed ID: 2526507
[TBL] [Abstract][Full Text] [Related]
12. Functional antagonism between IL-2 and PGA1 or PGJ2 in the control of proliferation of human cord blood-derived mononuclear cells.
Franzese O; Bonmassar E; Marcucci A; D'Onofrio C
Int J Immunopharmacol; 1996 Nov; 18(11):609-22. PubMed ID: 9089005
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction.
D'Onofrio C; Franzese O; De Marco A; Bonmassar E; Amici C
Leukemia; 1994 Jun; 8(6):1045-56. PubMed ID: 7516027
[TBL] [Abstract][Full Text] [Related]
14. [Development of antineoplastic prostaglandins].
Fukushima M
Gan To Kagaku Ryoho; 1983 Sep; 10(9):1930-5. PubMed ID: 6577812
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival time of sarcoma 180-bearing mice treated with lipid microspheres-entrapped antitumor marine coral prostanoids.
Honda A; Mori Y; Yamada Y; Nakaike S; Hayashi H; Otomo S
Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):413-6. PubMed ID: 3187200
[TBL] [Abstract][Full Text] [Related]
16. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells.
D'Onofrio C; Amici C; Puglianiello A; Faraoni I; Lanzilli G; Santoro MG; Bonmassar E
Int J Cancer; 1992 May; 51(3):481-8. PubMed ID: 1592539
[TBL] [Abstract][Full Text] [Related]
17. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
Narumiya S; Fukushima M
J Pharmacol Exp Ther; 1986 Nov; 239(2):500-5. PubMed ID: 3772804
[TBL] [Abstract][Full Text] [Related]
18. Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition.
Li Z; Melandri F; Berdo I; Jansen M; Hunter L; Wright S; Valbrun D; Figueiredo-Pereira ME
Biochem Biophys Res Commun; 2004 Jul; 319(4):1171-80. PubMed ID: 15194490
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells.
Chinery R; Coffey RJ; Graves-Deal R; Kirkland SC; Sanchez SC; Zackert WE; Oates JA; Morrow JD
Cancer Res; 1999 Jun; 59(11):2739-46. PubMed ID: 10364000
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of serum constituents on apoptosis induced by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in WISH epithelial cells.
Berry EB; Sato TA; Mitchell MD; Stewart Gilmour R; Helliwell RJ
Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):191-7. PubMed ID: 15253890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
